List view / Grid view

Bruker Biospin



Accelerating timelines for development and manufacture of multi-specific antibodies

25 August 2022 | By ,

The critical need to rapidly develop new biological therapeutics was emphasised during the COVID-19 pandemic, prompting a sea-change in the speed with which development of complex biological medicines occurs. In parallel, the increasing demand for new molecular formats, such as multi-specific antibodies, to tackle a wide range of disease modalities…


Video: ASMS 2019: diaPASEF

2 July 2019 | By

The timsTOF Pro with diaPASEF enables deeper proteome coverage in a single 4D shotgun proteomics experiment, with highly reproducible qualitative and quantitative results - making it a near-ideal mass analyzer for proteomics.